Ozempic-Style Drugs Have Taken the World By Storm. Soon, They May Not Even Require a Needle.

In a 71-week, double-blind study, Novo Nordisk—creator of the popular weight loss drug Wegovy—says their oral semaglutide achieved nearly 17-pound weight loss on average.

View in Browser  DIGITAL ISSUES GEAR REVIEWS SUBSCRIBE Ozempic-Style Drugs Have Taken the World By Storm. Soon, They May Not Even Require a Needle. In a 71-week, double-blind study, Novo Nordisk—creator of the popular weight loss drug Wegovy—says their oral semaglutide achieved nearly 17-pound weight loss on average. Read More You Struggle to Fit Everything In Your Dishwasher. This Feature Could Solve Your Washing Headaches. You'll soon be arranging all of your dirty dishes into a single dishwasher load. Read More Ford and Google Just Mapped One of the U.S.' Most Iconic Trails The expedition across the TransAmerica Trail spanned over 30 days, covering just under 6,000 miles of trail stretching coast to coast. Read More Scientists Have Pinpointed Where Our Anxiety Comes From—and Might Be Able to Reverse It Scientists identified a gene in the amygdala that can cause anxiety by over-expressing itself. They treated that gene in mice and saw an instant change. Read More No Need to Wait—Shop These Early Black Friday Deals Now Here's the best early Black Friday deals you can shop now on home, tech, and gear. Read More Workers Were Building a Road—and Uncovered an Entire Viking Village Additional discoveries included the remains of horses and riders buried alongside each other, along with their equipment. Read More Need Assistance? Contact Us. Follow Us Unsubscribe | Manage Preferences | Privacy Notice | CA Notice at Collection Popular Mechanics is a publication of Hearst Magazines. ©2025 Hearst Magazine Media, Inc. All Rights Reserved. This email was sent by Hearst Magazines, 300 West 57th Street, New York, NY 10019-3779